Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Nephritis, Hereditary
- Treatment With Metformin in Chinese Children With Alport Syndrome
- A Study of ELX-02 in Patients With Alport Syndrome
- Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis
- Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
- Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)
- Atrasentan in Patients With Proteinuric Glomerular Diseases
- An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
- A Study of RG-012 in Subjects With Alport Syndrome
- A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
- Study of Lademirsen (SAR339375) in Patients With Alport Syndrome
- European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
- Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome
- Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome